MRI may reveal evidence of seizures, which may occasionally help diagnose NCSE (nonconvulsive status epilepticus)
Effects of GLP-1RA in the General Population The effects of GLP-1RA on mortality and weight loss outcomes have been studied in a variety of higher-risk populations, including subjects with obesity, higher cardiovascular risk, type 2 diabetes mellitus, and metabolic dysfunction-associated steatohepatitis (Table 1)
The discovery of robust predictors of treatment response could enable the prediction, from the outset, of a persons probable treatment journey, and thereby pave the way for precision medicine through the clinical implementation of combined phenotypic and genotypic prediction models
In clinical studies, semaglutide has demonstrated ~15% average weight loss, while tirzepatide has shown results of up to 20%+ body weight reduction in certain patient groups
This distinction trips up more people than any other aspect of tirzepatide dosing, which is why having a reliable dosage chart measured in units matters so much
Dischinger U, Ktzner L, Kovatcheva-Datchary P, Kleinschmidt H, Haas C, Perez J, et al
